Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Cervical Cancer
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the safety and effectiveness of immunotherapy in combination with chemotherapy and radiation (chemoradiation) for the treatment of advanced cervical cancer. Pembrolizumab, a type of immunotherapy called a checkpoint inhibitor, will be administered after or during chemoradiation.

Provided treatments

  • Drug: Pembrolizumab
  • Radiation: Brachytherapy
  • Drug: Cisplatin
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02635360. The sponsor of the trial is Linda R Duska and it is looking for 88 volunteers for the current phase.
Official trial title:
A Randomized Phase II Study of Chemoradiation and Pembrolizumab for Locally Advanced Cancer